The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-N-[7-hydroxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-b]pyridazin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide ID: ALA5202846
PubChem CID: 168293608
Max Phase: Preclinical
Molecular Formula: C28H27N9O3
Molecular Weight: 537.58
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(Nc2ncnc3cc(O)c(NC(=O)/C=C/[C@H]4CCCN4C)cc23)ccc1Oc1cnn2cnnc2c1
Standard InChI: InChI=1S/C28H27N9O3/c1-17-10-18(5-7-25(17)40-20-11-26-35-31-16-37(26)32-14-20)33-28-21-12-23(24(38)13-22(21)29-15-30-28)34-27(39)8-6-19-4-3-9-36(19)2/h5-8,10-16,19,38H,3-4,9H2,1-2H3,(H,34,39)(H,29,30,33)/b8-6+/t19-/m1/s1
Standard InChI Key: LLRHFPTXSRUXGC-ZLQZBKBYSA-N
Molfile:
RDKit 2D
40 45 0 0 0 0 0 0 0 0999 V2000
-1.4374 -1.2345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7228 -0.8222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0110 -1.2341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0110 -2.0593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7210 -2.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4374 -2.0630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7017 -0.8233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4166 -1.2357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4184 -2.0568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7068 -2.4734 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7017 0.0019 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4163 0.4144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4165 1.2397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1294 1.6504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8442 1.2376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8458 0.4165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1340 0.0001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1294 2.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5589 1.6503 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2735 1.2376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9881 1.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7028 1.2376 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7028 0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9881 -0.0001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2735 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1597 -0.8071 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3160 -0.1395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9803 -0.8934 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1521 -0.8219 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8666 -1.2345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5813 -0.8219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8666 -2.0597 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2960 -1.2345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1521 -2.4756 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.0106 -0.8219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0968 -0.0017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.9036 0.1698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.3160 -0.5444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7640 -1.1574 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.9776 -1.9545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
4 10 1 0
7 11 1 0
11 12 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
14 18 1 0
15 19 1 0
19 20 1 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 1 0
25 24 1 0
20 25 2 0
24 26 2 0
23 27 1 0
27 28 2 0
28 26 1 0
1 29 1 0
29 30 1 0
30 31 1 0
30 32 2 0
31 33 2 0
6 34 1 0
35 33 1 6
36 35 1 0
37 36 1 0
38 37 1 0
38 39 1 0
39 35 1 0
39 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 537.58Molecular Weight (Monoisotopic): 537.2237AlogP: 4.21#Rotatable Bonds: 7Polar Surface Area: 142.69Molecular Species: BASEHBA: 11HBD: 3#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.77CX Basic pKa: 8.75CX LogP: 1.87CX LogD: 1.84Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.20Np Likeness Score: -1.05
References 1. Li D, Tu Y, Jin K, Duan L, Hong Y, Xu J, Chen N, Zhang Z, Zuo H, Gong W, Zhang J, Wang Q, Qian H, Wang X, Ke Y, Xia G.. (2022) Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment., 65 (7.0): [PMID:35319895 ] [10.1021/acs.jmedchem.1c00710 ]